Industries > Pharma > Global Anaesthesia Drugs Market 2019-2029

Back to Pharma Reports

Global Anaesthesia Drugs Market 2019-2029

Local Anaesthesia, General Anaesthesia, Inhalation Anaesthesia, Intravenous Anaesthesia, Topical Anaesthesia, Benzocaine, Bupivacaine, Chloroprocaine, Lidocaine, Prilocaine, Ropivacaine, Desflurane, Dexmedetomidine, Midazolam, Propofol, Remifentanil, Sevoflurane and Others

PUBLISHED: 19 March 2019

PAGES: 241

PRODUCT CODE: PHA0358

SUBMARKET: Medical Devices Therapeutic Drugs

SKU: PHA0358 Categories: Medical Devices, Pharma, Therapeutic Drugs Tags: PHA0358, PHA0361

The global anaesthesia drugs market is expected to reach $11.8bn in 2024 and is estimated to grow at a CAGR of 3.9% from 2019-2024. The local anaesthesia segment accounted for the largest share in the anaesthesia drugs market in 2018.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 241-page report you will receive 129 tables and 117 figures– all unavailable elsewhere.

The 241-page report provides clear detailed insight into the global anaesthesia drugs market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

• Global Anaesthesia Drugs Market forecasts from 2019-2029

• Along with revenue prediction for the overall world market for anaesthesia drugs market, our investigation shows forecasts to 2029 for the market segmented by type:
• Local Anaesthesia Drugs
• General Anaesthesia Drugs

• This report also provides revenue forecast to 2029 for these local anaesthesia drugs:
• Benzocaine
• Bupivacaine
• Chloroprocaine
• Lidocaine
• Prilocaine
• Ropivacaine
• Others

• This report also provides revenue forecast to 2029 for these general anaesthesia drugs:
• Desflurane
• Dexmedetomidine
• Midazolam
• Propofol
• Remifentanil
• Sevoflurane
• Others

• This report shows forecasts to 2029 for the market segmented by route of administration:
• Inhalation Anaesthesia Drugs
• Intravenous Anaesthesia Drugs
• Topical Anaesthesia Drugs

• Our analyses show individual revenue forecasts to 2029 for these regional and national markets:
• North America: US and Canada
• Europe: Germany, UK, France, Italy, Spain, Rest of Europe
• Asia-Pacific: Japan, China, India, Rest of Asia-Pacific
• RoW: Brazil, Mexico, Russia, South Africa

Each regional and national market is further segmented by type, drug and route of administration.

• This report discusses these selected leading companies:
• Baxter International, Inc.
• AbbVie
• PAION AG
• Pfizer
• Hameln Pharmaceuticals
• AstraZeneca
• Fresenius Kabi
• Maruishi Pharmaceuticals
• Pacira Pharmaceuticals, Inc

Depending on data availability, we provide for each company: a company overview, financial information, recent development, product portfolio and a SWOT analysis.

• This report discusses promising drug candidates which are under development for the anaesthesia drugs market.

• Our study discusses trends as well as factors that drive and challenge the anaesthesia drugs market.

Visiongain’s study is intended for anyone requiring commercial analyses for the anaesthesia drugs market. You find data, trends and predictions.

Buy our report today Anaesthesia Drugs Market Analysis : Local Anaesthesia, General Anaesthesia, Inhalation Anaesthesia, Intravenous Anaesthesia, Topical Anaesthesia, Benzocaine, Bupivacaine, Chloroprocaine, Lidocaine, Prilocaine, Ropivacaine, Desflurane, Dexmedetomidine, Midazolam, Propofol, Remifentanil, Sevoflurane and Others.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

1. Report Overview

1.1 Why You Should Read This Report

1.2 How This Report Delivers

1.3 Key Questions Answered by This Analytical Report Include:

1.4 Who is This Report For?

1.5 Methodology

1.5.1 Primary Research

1.5.2 Secondary Research

1.5.3 Market Evaluation & Forecasting Methodology

1.6 Frequently Asked Questions (FAQ)

1.7 Associated Visiongain Reports

1.8 About Visiongain

2. Introduction to Anaesthetic Drugs

2.1 What is an Anaesthesia?

2.1.1 Types of Anaesthetics

2.1.1.1 General Anaesthetics

2.1.1.2 Local Anaesthetics

2.1.1.3 Sedation

2.2 What are the Risk and Side Effects of Anaesthesia Drugs?

2.2.1 Localized side effects

2.2.2 General side effects

2.3 Epidemiology of Anaesthetic Drugs

2.4 Humanistic and Economic Burden

2.4.1 Mortality

2.4.2 Morbidity

2.4.3 Economic Impact

3. Introduction to the Global Anaesthesia Drugs Market

4. Global Anaesthesia Drugs Market Forecast 2019-2029

5. Global Anaesthesia Drugs Market Forecast by Type, 2019-2029

5.1 Global Local Anaesthesia Drugs Market 2019-2029

5.2 Global General Anaesthesia Drugs Market 2019-2029

6. Global Anaesthesia Drugs Market Forecast by Routes of Administration, 2019-2029

6.1 Global Inhalation Anaesthesia Drugs Market 2019-2029

6.2 Global Intravenous Anaesthesia Drugs Market 2019-2029

6.3 Global Topical Anaesthesia Drugs Market 2019-2029

7. Global Anaesthesia Drugs by Regional and National Markets, 2019-2029

7.1 Anaesthesia Drugs Market by Region, 2018

7.2 North America Anaesthesia Drugs Market

7.2.1 North America Anaesthesia Drugs Market Forecast 2019-2029

7.2.2 North America Anaesthesia Drugs Market Forecast by Country, 2019-2029

7.2.3 North America Anaesthesia Drugs Market Forecast by Type, 2019-2029

7.2.4 North America Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029

7.2.5 U.S. Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029

7.2.6 Canada Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029

7.3 Europe Anaesthesia Drugs Market

7.3.1 Europe Anaesthesia Drugs Market Forecast 2019-2029

7.3.2 Europe Anaesthesia Drugs Market Forecast by Country, 2019-2029

7.3.3 Europe Anaesthesia Drugs Market Forecast by Type, 2019-2029

7.3.4 Europe Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029

7.3.5 Germany Anaesthesia Drugs Market Forecast by Route of Administration 2019-2029

7.3.6 UK Anaesthesia Drugs Market Forecast by Route of Administration 2019-2029

7.3.7 France Anaesthesia Drugs Market by Route of Administration, 2019-2029

7.3.8 Italy Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029

7.3.9 Spain Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029

7.3.10 Rest of Europe Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029

7.4 Asia-Pacific Anaesthesia Drugs Market

7.4.1 Asia-Pacific Anaesthesia Drugs Market Forecast 2019-2029

7.4.2 Asia-Pacific Anaesthesia Market Forecast by Country, 2019-2029

7.4.3 Asia-Pacific Anaesthesia Drugs Market Forecast by Type, 2019-2029

7.4.4 Asia-Pacific Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029

7.4.5 Japan Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029

7.4.6 China Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029

7.4.7 India Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029

7.4.8 Rest of Asia-Pacific Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029

7.5 RoW Anaesthesia Drugs Market

7.5.1 RoW Anaesthesia Drugs Market Forecast 2019-2029

7.5.2 RoW Anaesthesia Drugs Market Forecast by Country, 2019-2029

7.5.3 RoW Anaesthesia Drugs Market Forecast by Type, 2019-2029

7.5.4 RoW Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029

7.5.6 Brazil Anaesthesia Market by Route of Administration, 2019-2029

7.5.7 Mexico Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029

7.5.8 Russia Anaesthesia Drugs Market Forecast by Route of Administration, 2017-2029

7.5.9 South Africa Anaesthesia Market Forecast by Route of Administration, 2017-2029

8. Leading Drugs in the Global Anaesthesia Drugs Market, 2018

8.1 Propofol (Diprivan)

8.2 Sevoflurane (Sojourn, Ultane)

8.3 Remifentanil

8.4 Midazolam

8.5 Lidocaine

8.6 Ropivacaine

9. Market Growth Drivers

9.1 Increasing incidence of surgeries

9.2 Increasing cosmetic surgeries

9.3 Designated ICD-10 Code

9.4 Demand for general anaesthesia drugs

9.5 Increased investment in R&D

9.6 Advancements in medical power supply products

9.7 Rise in Geriatric population

10. Market Challenges

10.1 Healthcare consolidation

10.2 Stringent Regulatory Guidelines

10.3 Paucity of large, prospective and collaborative outcome studies

11. Market Trends

11.1 Advances in modern technologies

11.2 Strategic alliances among key players in the market

11.3 Expansion of healthcare sector in developing countries due to growing investments by major players

11.4 Advancements in drug delivery methods

11.5 Paucity of new drugs to change the practice of operating room Anaesthesia

11.6 Expect improved safety statistics regarding anaesthesia mortality and morbidity

11.7 Rising trend of home healthcare

12. Pipeline Molecules

12.1 Promising Potential Pipeline Molecules

12.1.1 Phase IV Molecules

12.1.1.1 Exparel (Bupivacaine Liposome)

12.1.2 Phase III Molecules

12.1.2.1 Remimazolam (CNS 7056)

12.1.3 Phase I Molecules

12.1.3.1 Cyclopropyl-methoxycarbonyl metomidate (ABP-700)

12.1.3.2 Carboetomidate

12.1.3.3 JM-1232 (-) (MR04A3)

12.1.3.4 Propofol

12.1.3.5 PF0713

12.1.3.6 Fospropofol

12.1.3.7 AZD-3043 (TD4756)

13. Leading Companies in Global Anaesthetic Drugs Market, 2018

13.1 Baxter International Inc.

13.2 AbbVie Inc.

13.3 PAION AG

13.4 Pfizer Inc.

13.5 Hameln Pharmaceuticals Ltd.

13.6 AstraZeneca

13.7 Fresenius Kabi

13.8 Maruishi Pharmaceuticals

13.9 Pacira Pharmaceuticals Inc.

13.10 Hospira Inc. (Pfizer Inc.)

13.10.1. Hospira Inc.: Product Portfolio

13.10.2. Recent Developments

13.10.2.1 Sale of Hospira’s Medical Devices Business to Enhance Operating Efficiency

13.10.2.2 Pfizer Expands Manufacturing Capacity for Sterile Injectable

13.11 Sandoz International GmbH (Novartis A.G)

13.11.1. Sandoz (Novartis A.G): Product Portfolio

13.11.2. Sandoz (Novartis A.G): Recent Development

13.11.2.1 Launch of First Generic of Suprane, in the U.S. is likely to Foster Market Share

13.12 Piramal Critical Care Inc. (Piramal Group)

13.12.1. Piramal Critical Care Inc. (Piramal Group): Product Portfolio

13.12.2. Piramal Critical Care Inc.: Recent Development

13.12.2.1 Strategic Acquisition to Rapidly Expand Product Offerings

13.12.2.2 Launch of Desflurane in 2019

13.13 Mylan N.V.

13.13.1. Mylan N.V.: Product Portfolio

13.13.2. Mylan N.V.: Recent Development

13.13.2.1 Acquisition China Player to Expand Geographical Reach

13.14 Aurobindo Pharma

13.14.1. Aurobindo Pharma: Product Portfolio

13.14.2. Aurobindo Pharma: Recent Developments

13.14.2.1 ANDA Approval

14. Conclusions

Visiongain Report Sales Order Form

Associated Visiongain Reports

About Visiongain

Visiongain report evaluation form

List of Tables

Table 2.1 Type of Surgeries performed in 2010 and 2020 (%)

Table 4.1 Global Anaesthesia Drugs Market 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 4.2 Global Anaesthesia Drugs Market by Regional Market Forecast 2019-2029 ($bn, AGR %, Cumulative)

Table 4.3 Global Anaesthesia Drugs Market Forecast by Country 2019-2029 ($bn, AGR %, Cumulative)

Table 5.1 Global Local Anaesthesia Drugs Market 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 5.2 Global Local Anaesthesia Drugs Market by Drug, 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 5.3 Global General Anaesthesia Drugs Market 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 5.4 Global General Anaesthesia Drugs Market by Drug, 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 6.1 Global Inhalation Anaesthesia Drugs Market 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 6.2 Global Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 6.3 Global Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.1 North America Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.2 U.S. Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.3 Canada Anaesthesia Market Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.4 North America Local Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.5 North America Local Anaesthesia Drugs Market Forecast 2017-2029 by Drug: Revenue ($bn), AGR (%), CAGR (%)

Table 7.6 North America General Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.7 North America General Anaesthesia Drugs Market Forecast 2017-2029 by Drug: Revenue ($bn), AGR (%), CAGR (%)

Table 7.8 North America Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.9 North America Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.10 North America Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.11 U.S. Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.12 U.S. Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.13 U.S. Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.14 Canada Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.15 Canada Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.16 Canada Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.17 Europe Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.18 Germany Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.19 UK Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.20 France Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.21 Italy Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.22 Spain Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.23 Rest of Europe Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.24 Europe General Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.25 Europe General Anaesthesia Drugs Market Forecast 2017-2029 by Drug: Revenue ($bn), AGR (%), CAGR (%)

Table 7.26 Europe Local Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.27 Europe Local Anaesthesia Drugs Market Forecast 2017-2029 by Drug: Revenue ($bn), AGR (%), CAGR (%)

Table 7.28 Europe Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.29 Europe Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.30 Europe Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.31 Germany Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.32 Germany Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.33 Germany Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.34 UK Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.35 UK Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.36 UK Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.37 France Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.38 France Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.39 France Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.40 Italy Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.41 Italy Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.42 Italy Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.43 Spain Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.44 Spain Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.45 Spain Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.46 Rest of Europe Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.47 Rest of Europe Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.48 Rest of Europe Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.49 Asia-Pacific Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.50 Japan Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.51 China Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.52 India Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.53 Rest of Asia-Pacific Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.54 Asia-Pacific General Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.55 Asia Pacific General Anaesthesia Drugs Market Forecast 2017-2029 by Drug: Revenue ($bn), AGR (%), CAGR (%)

Table 7.56 Asia-Pacific Local Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.57 Asia Pacific Local Anaesthesia Drugs Market Forecast 2017-2029 by Drug: Revenue ($bn), AGR (%), CAGR (%)

Table 7.58 Asia-Pacific Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.59 Asia-Pacific Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.60 Asia-Pacific Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.61 Japan Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.62 Japan Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.63 Japan Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.64 China Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.65 China Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.66 China Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.67 India Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.68 India Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.69 India Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.70 Rest of Asia-Pacific Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.71 Rest of Asia-Pacific Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.72 Rest of Asia-Pacific Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.73 RoW Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.74 Brazil Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.75 Mexico Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.76 Russia Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.77 South Africa Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.78 Rest of RoW Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.79 RoW Local Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.80 RoW Local Anaesthesia Drugs Market Forecast 2017-2029 by Drug: Revenue ($bn), AGR (%), CAGR (%)

Table 7.81 RoW General Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.82 RoW General Anaesthesia Drugs Market Forecast 2017-2029 by Drug: Revenue ($bn), AGR (%), CAGR (%)

Table 7.83 RoW Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.84 RoW Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.85 RoW Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.86 Brazil Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.87 Brazil Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.88 Brazil Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.89 Mexico Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.90 Mexico Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.92 Mexico Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.92 Russia Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.93 Russia Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.94 Russia Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.95 South Africa Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.96 South Africa Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 7.97 South Africa Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)

Table 12.1 Active Pipeline Molecules under Development for Anaesthesia Drugs

Table 13.1 Baxter: Overview

Table 13.2 Baxter: Revenue ($m), Revenue Share (%) and AGR (%) Breakdown by Geographical Segment, 2016-2017

Table 13.3 AbbVie: Overview

Table 13.4 PAION AG: Overview

Table 13.5 Pfizer: Overview

Table 13.6 Hameln: Overview

Table 13.7 AstraZeneca: Overview

Table 13.8 Fresenius Kabi: Overview 2016

Table 13.9 Maruishi: Overview

Table 13.10 Pacira: Overview

Table 13.11 Hospira Inc.: Overview, 2017

Table 13.12 Hospira Inc.: Anaesthesia Drug Offerings

Table 13.13. Sandoz: Overview, 2017

Table 13.14. Sandoz.: Anaesthesia Drug Offerings

Table 13.15: Piramal Critical Care Inc.: Overview, 2017

Table 13.16. Piramal Critical Care Inc.: Anaesthesia Drug Offerings

Table 13.17: Mylan N.V.: Overview, 2017

Table 13.18: Mylan N.V..: Anaesthesia Drug Offerings

Table 13.19: Aurobindo Pharma: Overview, 2017

Table 13.20: Aurobindo Pharma: Anaesthesia Drug Offerings

List of Figures

Figure 4.1 Global Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%)

Figure 4.2 Global Anaesthesia Market by Region (%), 2017-2029

Figure 4.3 Global Anaesthesia Market by Type (%), 2017-2029

Figure 4.4 Global Anaesthesia Market by Route of Administration (%), 2017-2029

Figure 5.1 Global Local Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%)

Figure 5.2 Global Local Anaesthesia Drugs Market Forecast 2017-2029 by Drug: Revenue ($bn)

Figure 5.3 Global Local Anaesthesia Drugs Market by Drug in 2018 (%)

Figure 5.4 Global Local Anaesthesia Drugs Market by Drug in 2024 (%)

Figure 5.5 Global Local Anaesthesia Drugs Market by Drug in 2029 (%)

Figure 5.6 Global General Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%)

Figure 5.7 Global General Anaesthesia Drugs Market by Drug in 2018: Revenue ($bn)

Figure 5.8 Global General Anaesthesia Drugs Market by Drug in 2018 (%)

Figure 5.9 Global General Anaesthesia Drugs Market by Drug in 2024 (%)

Figure 5.10 Global General Anaesthesia Drugs Market by Drug in 2029 (%)

Figure 6.1 Global Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%)

Figure 6.2 Global Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%)

Figure 7.1 Anaesthesia Drugs Market by Region (% Share), 2018

Figure 7.2 Number of Inpatient Surgeries by Type in Canada, 2015-2016

Figure 7.3 North America Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%)

Figure 7.4 North America Anaesthesia Drugs Market Forecast by Country 2017-2029: Revenue ($bn)

Figure 7.5 North America Anaesthesia Drugs Market by Country: (% Share), 2018

Figure 7.6 North America Anaesthesia Drugs Market by Country: (% Share), 2024

Figure 7.7 North America Anaesthesia Drugs Market by Country: (% Share), 2029

Figure 7.8 North America Local Anaesthesia Drugs Market by Drug in 2018: Revenue ($bn)

Figure 7.9 North America Local Anaesthesia Drugs Market by Drug in 2018 (%)

Figure 7.10 North America Local Anaesthesia Drugs Market by Drug in 2024 (%)

Figure 7.11 North America Local Anaesthesia Drugs Market by Drug in 2029 (%)

Figure 7.12 North America General Anaesthesia Drugs Market by Drug in 2018: Revenue ($bn)

Figure 7.13 North America General Anaesthesia Drugs Market by Drug in 2018 (%)

Figure 7.14 North America General Anaesthesia Drugs Market by Drug in 2024 (%)

Figure 7.15 North America General Anaesthesia Drugs Market by Drug in 2029 (%)

Figure 7.16 North America Anaesthesia Drugs Market Forecast by Type 2017-2029: Revenue ($bn)

Figure 7.17 North America Anaesthesia Drugs Market by Type: (% Share), 2018

Figure 7.18 North America Anaesthesia Drugs Market by Type: (% Share), 2024

Figure 7.19 North America Anaesthesia Drugs Market by Type: (% Share), 2029

Figure 7.20 North America Anaesthesia Drugs Market Forecast by Route of Administration 2017-2029: Revenue ($bn)

Figure 7.21 North America Anaesthesia Drugs Market by Route of Administration: (% Share), 2018

Figure 7.22 North America Anaesthesia Drugs Market by Route of Administration: (% Share), 2024

Figure 7.23 North America Anaesthesia Drugs Market by Route of Administration: (% Share), 2029

Figure 7.24 Europe Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%)

Figure 7.25 Europe Anaesthesia Drugs Market Forecast by Country 2017-2029: Revenue ($bn)

Figure 7.26 Europe Anaesthesia Drugs Market by Country: (% Share), 2018

Figure 7.27 Europe Anaesthesia Drugs Market by Country: (% Share), 2024

Figure 7.28 Europe Anaesthesia Drugs Market by Country: (% Share), 2029

Figure 7.29 Europe General Anaesthesia Drugs Market by Drug in 2018: Revenue ($bn)

Figure 7.30 Europe General Anaesthesia Drugs Market by Drug in 2018 (%)

Figure 7.31 Europe General Anaesthesia Drugs Market by Drug in 2024 (%)

Figure 7.32 Europe General Anaesthesia Drugs Market by Drug in 2029 (%)

Figure 7.33 Europe Local Anaesthesia Drugs Market by Drug in 2018: Revenue ($bn)

Figure 7.34 Europe Local Anaesthesia Drugs Market by Drug in 2018 (%)

Figure 7.35 Europe Local Anaesthesia Drugs Market by Drug in 2024 (%)

Figure 7.36 Europe Local Anaesthesia Drugs Market by Drug in 2029 (%)

Figure 7.37 Europe Anaesthesia Drugs Market Forecast by Type 2017-2029: Revenue ($bn)

Figure 7.38 Europe Anaesthesia Drugs Market by Type: (% Share), 2018

Figure 7.39 Europe Anaesthesia Drugs Market by Type: (% Share), 2024

Figure 7.40 Europe Anaesthesia Drugs Market by Type: (% Share), 2029

Figure 7.41 Europe Anaesthesia Drugs Market Forecast by Route of Administration 2017-2029: Revenue ($bn)

Figure 7.42 Europe Anaesthesia Drugs Market by Route of Administration: (% Share), 2018

Figure 7.43 Europe Anaesthesia Drugs Market by Route of Administration: (% Share), 2024

Figure 7.44 Europe Anaesthesia Drugs Market by Route of Administration: (% Share), 2029

Figure 7.45 Asia-Pacific Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%)

Figure 7.46 Asia-Pacific Anaesthesia Drugs Market Forecast by Country 2017-2029: Revenue ($bn)

Figure 7.47 Asia-Pacific Anaesthesia Drugs Market by Country: (% Share), 2018

Figure 7.48 Asia-Pacific Anaesthesia Drugs Market by Country: (% Share), 2024

Figure 7.49 Asia-Pacific Anaesthesia Drugs Market by Country: (% Share), 2029

Figure 7.50 Asia Pacific General Anaesthesia Drugs Market by Drug in 2018 (%)

Figure 7.51 Asia Pacific General Anaesthesia Drugs Market by Drug in 2018 (%)

Figure 7.52 Asia Pacific General Anaesthesia Drugs Market by Drug in 2024 (%)

Figure 7.53 Asia Pacific General Anaesthesia Drugs Market by Drug in 2029 (%)

Figure 7.54 Asia Pacific Local Anaesthesia Drugs Market by Drug in 2018: Revenue ($bn)

Figure 7.55 Asia Pacific Local Anaesthesia Drugs Market by Drug in 2018 (%)

Figure 7.56 Asia Pacific Local Anaesthesia Drugs Market by Drug in 2024 (%)

Figure 7.57 Asia Pacific Local Anaesthesia Drugs Market by Drug in 2029 (%)

Figure 7.58 Asia-Pacific Anaesthesia Drugs Market Forecast by Type 2017-2029: Revenue ($bn)

Figure 7.59 Asia-Pacific Anaesthesia Drugs Market by Type: (% Share), 2018

Figure 7.60 Asia-Pacific Anaesthesia Drugs Market by Type: (% Share), 2024

Figure 7.61 Asia-Pacific Anaesthesia Drugs Market by Type: (% Share), 2029

Figure 7.62 Asia-Pacific Anaesthesia Drugs Market Forecast by Route of Administration 2017-2029: Revenue ($bn)

Figure 7.63 Asia-Pacific Anaesthesia Drugs Market by Route of Administration: (% Share), 2018

Figure 7.64 Asia-Pacific Anaesthesia Drugs Market by Route of Administration: (% Share), 2024

Figure 7.65 Asia-Pacific Anaesthesia Drugs Market by Route of Administration: (% Share), 2029

Figure 7.66 RoW Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%)

Figure 7.67 RoW Anaesthesia Drugs Market Forecast by Country 2017-2029: Revenue ($bn)

Figure 7.68 RoW Anaesthesia Drugs Market by Country: (% Share), 2018

Figure 7.69 RoW Anaesthesia Drugs Market by Country: (% Share), 2024

Figure 7.70 RoW Anaesthesia Drugs Market by Country: (% Share), 2029

Figure 7.71 RoW Local Anaesthesia Drugs Market by Drug in 2018 (%)

Figure 7.72 RoW Local Anaesthesia Drugs Market by Drug in 2018 (%)

Figure 7.73 RoW Local Anaesthesia Drugs Market by Drug in 2024 (%)

Figure 7.74 RoW Local Anaesthesia Drugs Market by Drug in 2029 (%)

Figure 7.75 RoW General Anaesthesia Drugs Market by Drug in 2018: Revenue ($bn)

Figure 7.76 RoW General Anaesthesia Drugs Market by Drug in 2018 (%)

Figure 7.77 RoW General Anaesthesia Drugs Market by Drug in 2024 (%)

Figure 7.78 RoW General Anaesthesia Drugs Market by Drug in 2029 (%)

Figure 7.79 RoW Anaesthesia Drugs Market Forecast by Type 2017-2029: Revenue ($bn)

Figure 7.80 RoW Anaesthesia Drugs Market by Type: (% Share), 2018

Figure 7.81 RoW Anaesthesia Drugs Market by Type: (% Share), 2024

Figure 7.82 RoW Anaesthesia Drugs Market by Type: (% Share), 2029

Figure 7.83 RoW Anaesthesia Drugs Market Forecast by Route of Administration 2017-2029: Revenue ($bn)

Figure 7.84 RoW Anaesthesia Drugs Market by Route of Administration: (% Share), 2018

Figure 7.85 RoW Anaesthesia Drugs Market by Route of Administration: (% Share), 2024

Figure 7.86 RoW Anaesthesia Drugs Market by Route of Administration: (% Share), 202

Figure 13.1 Baxter: Revenue Share (%) Breakdown by Geographical Segment, 2017

Figure 13.2 Baxter: SWOT Analysis

Figure 13.3 AbbVie Inc.: Revenue Share (%) Breakdown by Product Segment, 2017

Figure 13.4 AbbVie Inc.: Revenue Share (%) Breakdown by Geographic Area, 2017

Figure 13.5 AbbVie Inc.: Sevoflurane Drug Revenue Share (%) Breakdown, 2017

Figure 13.6 AbbVie: SWOT Analysis

Figure 13.7 PAION AG: SWOT Analysis

Figure 13.8 AstraZeneca: SWOT Analysis

Figure 13.9 Fresenius Kabi: Revenue Share (%) Breakdown by Geographic Area, 2016-2017

Figure 13.10 Fresenius Kabi: Revenue Share (%) Breakdown by Product Segment, 2016-2017

Figure 13.11 Fresenius Kabi: SWOT Analysis

Figure 13.12 Maruishi Pharmaceuticals: SWOT Analysis

Figure 13.13 Pacira Pharmaceuticals: SWOT Analysis

Figure 14.1 Anaesthesia Market by Type (% share 2019 & 2029)

Figure 14.2 Anaesthesia Market by Route of Administration (% share 2019 & 2029)

Abbott

AbbVie

Alcon

AltaSelect S.r.l.

AmerisourceBergen Corporation

AstraZeneca

Aurobindo Pharma Ltd

AuroMedics

Baxter

Cardinal Health, Inc.

Fresenius Kabi

Hameln Pharmaceuticals GmbH

Hameln Pharmaceuticals Ltd.

Hameln RDS GmbH

Hospira Inc.

ICI India Ltd.

ICU Medical Inc.

Janssen Pharmaceutica NV

Jiangsu Hengrui Medicine Co.

Maruishi Pharmaceuticals

McKesson Corporation

McPherson

Meda Aktiebolag

Minrad Inc.

Mylan

Neon Laboratories Ltd.

Novartis

Pacira Pharmaceuticals, Inc.

PAION AG

Pfizer

Piramal Critical Care Inc.

Piramal Group

Rhodia Organique Ltd.

Roche

RxElite Inc.

Sandoz International GmbH

Siegfried Group

St. Renatus LLC

Stemcentrx, Inc.

List of Other Organizations Mentioned in the Report

American Society of Aesthetic Plastic Surgery (ASAPS)

American Society of Anesthesiologists

American Society of Plastic Surgeons

Centers for Disease Control and Prevention (CDC)

European Medicines Agency (EMA)

Food and Drug Administration (FDA)

French Ministry of Health

International Narcotics Control Bureau

International Society of Aesthetic Plastic Surgery (ISAPS)

Japanese Ministry of Health, Labour and Welfare

Massachusetts General Hospital

Medicines and Healthcare Products Regulatory Agency (MHRA)

Multiple Sclerosis Foundation

National Central Cancer Registry

National Development and Reform Commission (NDRC)

United Nations Narcotics Control Bureau

United States Department of Defense

United States Department of Veterans Affairs

US Census Bureau

World Health Organization (WHO)

Download sample pages

Complete the form below to download your free sample pages for Global Anaesthesia Drugs Market 2019-2029

Download sample pages

Complete the form below to download your free sample pages for Global Anaesthesia Drugs Market 2019-2029

Case studies

Need customized work?

Report overview

Methodology

Client testimonials

Pharmaceutical industry associations

American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia

Connect with us

Visiongain Pharma

Latest Pharma news

Visiongain Publishes Automation in Biopharma Industry Market Report 2023-2033

The global Automation in Biopharma Industry market was valued at US$1,784.1 million in 2022 and is projected to grow at a CAGR of 5.7% during the forecast period 2023-2033.

20 March 2023

READ

Visiongain Publishes eClinical Solutions Market Report 2023-2033

The global eClinical Solutions market was valued at US$8.03 billion in 2022 and is projected to grow at a CAGR of 13.09% during the forecast period 2023-2033.

17 March 2023

READ

Visiongain Publishes Therapeutic Respiratory Devices Market Report 2023-2033

The global Therapeutic Respiratory Devices market was valued at US$59.49 billion in 2022 and is projected to grow at a CAGR of 8.02% during the forecast period 2023-2033.

15 March 2023

READ

Visiongain Publishes Regenerative Medicine Market Report 2023-2033

The global Regenerative Medicine market was valued at US$ 50.37 billion in 2022 and is projected to grow at a CAGR of 18.40% during the forecast period 2023-2033.

10 March 2023

READ

Industries > Pharma > Global Anaesthesia Drugs Market 2019-2029

Back to Pharma Reports

Global Anaesthesia Drugs Market 2019-2029

Local Anaesthesia, General Anaesthesia, Inhalation Anaesthesia, Intravenous Anaesthesia, Topical Anaesthesia, Benzocaine, Bupivacaine, Chloroprocaine, Lidocaine, Prilocaine, Ropivacaine, Desflurane, Dexmedetomidine, Midazolam, Propofol, Remifentanil, Sevoflurane and Others

Download sample pages

Related reports

Next-Generation Biologics Market 2018-2028

Top 20 Pharmaceutical Wholesale & Distribution Organizations 2018

Global Asthma & COPD Therapies Market 2019-2029

Pharma Leader Series: Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market 2018

Translational Regenerative Medicine Market Forecast 2019-2029

Global Bioreactors Market 2019-2029

Pharma Leader Series: Top Generic Drug Producers Market Forecast 2019-2029

Global Pre-Filled Syringes Market Forecast 2019-2029

Top 20 Vaccines Manufacturers 2019

Top 50 Bioreactor Manufacturers 2019

Download sample pages

Share

Connect with us

Latest Pharma news

Visiongain Publishes Automation in Biopharma Industry Market Report 2023-2033

Visiongain Publishes eClinical Solutions Market Report 2023-2033

Visiongain Publishes Therapeutic Respiratory Devices Market Report 2023-2033

Visiongain Publishes Regenerative Medicine Market Report 2023-2033

Our Clients